Form 4: Mineralys Therapeutics CFO Adam Levy Sells Shares Under 10b5-1 Trading Plan

Mineralys Therapeutics CFO Adam Levy sold 96,815 shares of common stock at a weighted-average price of $12.9393 per share under a pre-arranged 10b5-1 trading plan.

Summary

• On June 11, 2024, Adam Scott Levy, CFO and Secretary of Mineralys Therapeutics, Inc., sold 96,815 shares of common stock.
• The sale was executed under a Rule 10b5-1 trading plan adopted on November 14, 2023.
• The weighted-average price of the shares sold was $12.9393, with individual transactions ranging from $12.79 to $13.29.
• Following the transaction, Levy directly owns 255,462 shares of Mineralys Therapeutics, Inc.
• This balance includes 1,466 shares purchased under the Mineralys Therapeutics, Inc. 2023 Employee Stock Purchase Plan that were not previously reported.

Sentiment

Score: 5

Explanation: Neutral sentiment as the sale was conducted under a pre-arranged trading plan. The impact on investor sentiment will depend on market perception and company performance.

Positives

• The sale was conducted under a pre-arranged 10b5-1 trading plan, indicating it was planned well in advance and not based on immediate insider knowledge.
• The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

Negatives

• The sale of a significant number of shares by a high-ranking officer could be perceived negatively by investors, potentially signaling a lack of confidence in the company's short-term prospects.

Risks

• Further sales by insiders could put downward pressure on the stock price.
• Investor sentiment may be negatively affected by the perception of insider selling.

Industry Context

Insider sales are a common occurrence in publicly traded companies. Investors often monitor these transactions to gauge executive sentiment and potential future performance. Sales under 10b5-1 plans are generally viewed as less concerning since they are pre-arranged and not based on immediate insider information.

Comparison to Industry Standards

• It's common for executives to utilize 10b5-1 trading plans to diversify their holdings or manage personal finances.
• The volume of shares sold is significant but not unusual for a CFO of a company of Mineralys' size.
• Comparable companies often see similar insider trading activity, with the impact on stock price varying based on overall market conditions and company performance.

Stakeholder Impact

• Shareholders may react to the news of the CFO's share sale, potentially impacting the stock price.
• Employees may be concerned about the implications of insider selling, although the 10b5-1 plan mitigates some of this concern.

Key Dates